Maybe the bias there is in expecting that the competitor’s drug is similar to their own (therefore also good), and that it’s newer than the standard treatment (and so more advanced and better).
Maybe the bias there is in expecting that the competitor’s drug is similar to their own (therefore also good), and that it’s newer than the standard treatment (and so more advanced and better).